4SC AG organizacji RSI
Jaka jest wartość RSI organizacji 4SC AG?
Wartość RSI organizacji 4SC AG to 80.28
Jaka jest definicja RSI?
Wskaźnik względnej siły (Relative strength index - RSI 14) jest wskaźnikiem technicznym, który plasuje się pomiędzy wskaźnikami momentu i mierzy prędkość i zmianę ceny. Jego wartość wynosi od 0 do 100 i służy do scharakteryzowania stanu sprzed zakupu i przedpłaty.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI firm w Health Care sektor na XETRA w porównaniu do 4SC AG
Czym się zajmuję organizacja 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Firmy z rsi podobne do 4SC AG
- Wartość RSI organizacji CuriosityStream to 80.24
- Wartość RSI organizacji iShares VI Public - iShares Euro Corporate Bond s UCITS ETF to 80.24
- Wartość RSI organizacji Ventus 2 VCT Plc to 80.24
- Wartość RSI organizacji Amego Capital Corp to 80.26
- Wartość RSI organizacji Kamdhenu to 80.27
- Wartość RSI organizacji IGG Inc to 80.27
- Wartość RSI organizacji 4SC AG to 80.28
- Wartość RSI organizacji ScandiVanadium Ltd to 80.29
- Wartość RSI organizacji Hawthorn Bancshares Inc to 80.29
- Wartość RSI organizacji Ceps Plc to 80.30
- Wartość RSI organizacji New England Realty Associates LP to 80.30
- Wartość RSI organizacji Zhong Ao Home to 80.31
- Wartość RSI organizacji Rama Steel Tubes to 80.31